Neuronatin regulates pancreatic beta cell insulin content and secretion
File(s)Copy of 120115-JCI-RG-RV-3_sd_298809.xls (43 KB)
Supporting information
Author(s)
Type
Journal Article
Abstract
Neuronatin (Nnat) is an imprinted gene implicated in human obesity and widely expressed in neuroendocrine and metabolic tissues in a hormone and nutrient-sensitive manner. However, its molecular and cellular functions and precise role in organismal physiology remain only partly defined. Here we demonstrate that mice lacking Nnat globally or specifically in β cells display impaired glucose-stimulated insulin secretion leading to defective glucose handling under conditions of nutrient-excess. In contrast, we report no evidence for any feeding or body weight phenotypes in global Nnat null mice. At the molecular level neuronatin augments insulin signal peptide cleavage by binding to the signal peptidase complex and facilitates translocation of the nascent preprohormone. Loss of neuronatin expression in β cells therefore reduces insulin content and blunts glucose-stimulated insulin secretion. Nnat expression, in turn, is glucose-regulated. This mechanism therefore represents a novel site of nutrient-sensitive control of β cell function and whole animal glucose homeostasis. These data also suggest a potential wider role for Nnat in the regulation of metabolism through the modulation of peptide processing events.
Date Issued
2018-08-01
Date Acceptance
2018-05-17
Citation
Journal of Clinical Investigation, 2018, 128 (8), pp.3369-3381
ISSN
0021-9738
Publisher
American Society for Clinical Investigation
Start Page
3369
End Page
3381
Journal / Book Title
Journal of Clinical Investigation
Volume
128
Issue
8
Copyright Statement
© 2018 American Society for Clinical Investigation
Sponsor
Wellcome Trust
Wellcome Trust
Medical Research Council
Wellcome Trust
Medical Research Council (MRC)
MRC Programme Grant
Medical Research Council (MRC)
Wellcome Trust
Wellcome Trust
Wellcome Trust
Medical Research Council (MRC)
Medical Research Council (MRC)
Medical Research Council (MRC)
INNOVATIVE MEDICINES INITIATIVE
Diabetes UK
Medical Research Council (MRC)
Medical Research Council (MRC)
Diabetes UK
Biotechnology and Biological Sciences Research Council (BBSRC)
Diabetes UK
The Royal Society
Medical Research Council (MRC)
Medical Research Council (MRC)
European Foundation for the Study of Diabetes
European Foundation for the Study of Diabetes
European Foundation for the Study of Diabetes
Diabetes UK
Sun Pharmaceutical Industries Limited
Diabetes UK
Diabetes UK
Grant Number
093082/Z/10/Z
511377
MC-A654-5QB40
098424/Z/12/ZR
MR/K001981/1
MR/R022259/1
MR/R010676/1
212625/Z/18/Z
097816/Z/11/ZR
105603/Z/14/Z
MR/N020472/1
MR/L02036X/1
MR/L02036X/1
115881
15 / 0005275
MR/M012646/1
R26199/CN001
15821
BB/J015873/1
12/0004601
WM100078
MR/K023667/1
16-0323
N/A
n/a
15/0005374
N/A
BDA number 13/0004672
13/0004672
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
SIGNAL PEPTIDASE COMPLEX
ENDOPLASMIC-RETICULUM
SACCHAROMYCES-CEREVISIAE
MEMBRANE TOPOLOGY
METABOLIC STATUS
GENE-EXPRESSION
INS GENE
PROTEIN
MICE
MUTATIONS
Beta cells
Cell Biology
Diabetes
Genetics
Insulin
Animals
Gene Expression Regulation
Glucose
Insulin
Insulin Secretion
Insulin-Secreting Cells
Membrane Proteins
Mice
Mice, Transgenic
Nerve Tissue Proteins
Animals
Mice, Transgenic
Mice
Insulin
Glucose
Membrane Proteins
Nerve Tissue Proteins
Gene Expression Regulation
Insulin-Secreting Cells
Insulin Secretion
Immunology
11 Medical and Health Sciences
Publication Status
Published
Date Publish Online
2018-06-04